These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32584421)

  • 1. Combined IL-6 and JAK/STAT inhibition therapy in COVID-19-related sHLH, potential game changer.
    Portsmore S; Tran Nguyen TN; Beacham E; Neelakantan P
    Br J Haematol; 2020 Aug; 190(4):525-528. PubMed ID: 32584421
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids.
    Miao Y; Fan L; Li JY
    Front Immunol; 2020; 11():1445. PubMed ID: 32612616
    [No Abstract]   [Full Text] [Related]  

  • 3. Falciparum malaria-induced secondary hemophagocytic lymphohistiocytosis successfully treated with ruxolitinib.
    Fuchs A; Orth HM; Germing U; Kondakci M; Holtfreter M; Feldt T; Jensen BE; Häussinger D
    Int J Infect Dis; 2020 Nov; 100():382-385. PubMed ID: 32777582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: A case series.
    Hansen S; Alduaij W; Biggs CM; Belga S; Luecke K; Merkeley H; Chen LYC
    Eur J Haematol; 2021 May; 106(5):654-661. PubMed ID: 33523540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruxolitinib for tocilizumab-refractory severe COVID-19 infection.
    Innes AJ; Cook LB; Marks S; Bataillard E; Crossette-Thambiah C; Sivasubramaniam G; Apperley J; Milojkovic D
    Br J Haematol; 2020 Aug; 190(4):e198-e200. PubMed ID: 32593183
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunopathogenesis and treatment of cytokine storm in COVID-19.
    Kim JS; Lee JY; Yang JW; Lee KH; Effenberger M; Szpirt W; Kronbichler A; Shin JI
    Theranostics; 2021; 11(1):316-329. PubMed ID: 33391477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation.
    Meyer LK; Verbist KC; Albeituni S; Scull BP; Bassett RC; Stroh AN; Tillman H; Allen CE; Hermiston ML; Nichols KE
    Blood; 2020 Aug; 136(6):657-668. PubMed ID: 32530039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruxolitinib for the treatment of lymphoma-associated hemophagocytic lymphohistiocytosis: A cautionary tale.
    Trantham T; Auten J; Muluneh B; Van Deventer H
    J Oncol Pharm Pract; 2020 Jun; 26(4):1005-1008. PubMed ID: 31575356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Janus Family kinase (JAK) inhibitors in HLH and severe COVID-19.
    Wilcox RA
    Am J Hematol; 2020 Dec; 95(12):1448-1451. PubMed ID: 32918336
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 in a patient with idiopathic pulmonary fibrosis successfully treated with Ruxolitinib.
    Caradec E; Mouren D; Zrounba M; Azoulay LD; Blandin C; Ivanoff S; Levy V; Brillet PY; Nunes H; Uzunhan Y
    Respir Med Res; 2021 May; 79():100799. PubMed ID: 33242734
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report.
    Tholin B; Hauge MT; Aukrust P; Fehrle L; Tvedt TH
    J Med Case Rep; 2020 Oct; 14(1):187. PubMed ID: 33054818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ruxolitinib-loaded cytokine nanosponge alleviated the cytokine storm and dampened macrophage overactivation for the treatment of hemophagocytic lymphohistiocytosis.
    Wang H; Wang Y; Liu H; Li X; Sun C; Pang Z; Zhang B; Hu Y
    Int J Pharm; 2024 May; 657():124127. PubMed ID: 38621611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
    Meazza Prina M; Martini F; Bracchi F; Di Mauro D; Fargnoli A; Motta M; Giussani C; Gobbin G; Taverna M; D'Alessio A
    BMC Infect Dis; 2021 Aug; 21(1):811. PubMed ID: 34388982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia.
    D'Alessio A; Del Poggio P; Bracchi F; Cesana G; Sertori N; Di Mauro D; Fargnoli A; Motta M; Giussani C; Moro P; Vitale G; Giacomini M; Borra G
    Leukemia; 2021 Feb; 35(2):635-638. PubMed ID: 33173161
    [No Abstract]   [Full Text] [Related]  

  • 15. Helmet mask and tocilizumab for a patient with hemophagocytic lymphohistiocytosis syndrome and COVID-19: a case report.
    Eroglu A; Kartal S; Saral OB
    Braz J Anesthesiol; 2021; 71(1):79-83. PubMed ID: 33518836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance?
    Guisado Hernández P; Blanco Lobo P; Villaoslada I; de Felipe B; Lucena JM; Martín Gutierrez G; Castro MJ; Gutiérrez Valencia A; Sánchez Codez MI; Gaboli M; Neth O; Olbrich P
    J Clin Immunol; 2021 Oct; 41(7):1502-1506. PubMed ID: 34109505
    [No Abstract]   [Full Text] [Related]  

  • 17. Expanding treatment options by selectively targeting the cytokine storm with ruxolitinib in primary hemophagocytic lymphohistiocytosis.
    Van Laar JAM
    Haematologica; 2024 Feb; 109(2):374-375. PubMed ID: 37675517
    [No Abstract]   [Full Text] [Related]  

  • 18. Ruxolitinib for Severe COVID-19-Related Hyperinflammation in Nonresponders to Steroids.
    Sarmiento M; Rojas P; Jerez J; Bertín P; Campbell J; García MJ; Pereira J; Triantafilo N; Ocqueteau M
    Acta Haematol; 2021; 144(6):620-626. PubMed ID: 34111867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophagocytic lymphohistiocytosis in COVID-19: Case reports of a stepwise approach.
    Schnaubelt S; Tihanyi D; Strassl R; Schmidt R; Anders S; Laggner AN; Agis H; Domanovits H
    Medicine (Baltimore); 2021 Mar; 100(12):e25170. PubMed ID: 33761694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.
    Ahmed A; Merrill SA; Alsawah F; Bockenstedt P; Campagnaro E; Devata S; Gitlin SD; Kaminski M; Cusick A; Phillips T; Sood S; Talpaz M; Quiery A; Boonstra PS; Wilcox RA
    Lancet Haematol; 2019 Dec; 6(12):e630-e637. PubMed ID: 31537486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.